|
1BMG
CRYSTAL STRUCTURE OF BOVINE BETA2-MICROGLOBULIN
Deposited 1995-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
21–118(98 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
R-free 0.290
|
|
2XFX
cattle MHC class I N01301 presenting an 11mer from Theileria parva
Deposited 2010-05-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
20–118(99 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;20% PEG 8000, 50MM POTASSIUM PHOSPHATE, PH 7.0
|
Resolution 1.90 Å
R-free 0.238
|
|
3L9R
Crystal structure of bovine CD1b3 with endogenously bound ligands
Deposited 2010-01-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
21–118(98 aa)
Fragment:UNP residues 21-118
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
L9R (2S)-3-(octadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;100 mM Na cacodylate pH 6.5, 2 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.30 Å
R-free 0.248
|
|
3L9R
Crystal structure of bovine CD1b3 with endogenously bound ligands
Deposited 2010-01-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
21–118(98 aa)
Fragment:UNP residues 21-118
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
GOL GLYCEROL × 3
L9Q (1S)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;100 mM Na cacodylate pH 6.5, 2 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.30 Å
R-free 0.248
|
|
3L9R
Crystal structure of bovine CD1b3 with endogenously bound ligands
Deposited 2010-01-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
21–118(98 aa)
Fragment:UNP residues 21-118
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
L9R (2S)-3-(octadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;100 mM Na cacodylate pH 6.5, 2 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.30 Å
R-free 0.248
|
|
3L9R
Crystal structure of bovine CD1b3 with endogenously bound ligands
Deposited 2010-01-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
21–118(98 aa)
Fragment:UNP residues 21-118
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
GOL GLYCEROL × 4
L9Q (1S)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;100 mM Na cacodylate pH 6.5, 2 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.30 Å
R-free 0.248
|
|
3PWV
An immmunodominant CTL epitope from rinderpest virus presented by cattle MHC class I molecule N*01801 (BoLA-A11)
Deposited 2010-12-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
21–118(98 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291 K;pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.70 Å
R-free 0.232
|
|
3PWV
An immmunodominant CTL epitope from rinderpest virus presented by cattle MHC class I molecule N*01801 (BoLA-A11)
Deposited 2010-12-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
21–118(98 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291 K;pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.70 Å
R-free 0.232
|
|
4F7C
Crystal structure of bovine CD1d with bound C12-di-sulfatide
Deposited 2012-05-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
21–118(98 aa)
Fragment:UNP residues 21-118
|
Not recorded
|
0SG N-{(2S,3R,4E)-1-[(3,6-di-O-sulfo-beta-D-galactopyranosyl)oxy]-3-hydroxyoctadec-4-en-2-yl}dodecanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;20% PEG3350, 200 mM sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.86 Å
R-free 0.291
|
|
4F7C
Crystal structure of bovine CD1d with bound C12-di-sulfatide
Deposited 2012-05-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
21–118(98 aa)
Fragment:UNP residues 21-118
|
Not recorded
|
0SG N-{(2S,3R,4E)-1-[(3,6-di-O-sulfo-beta-D-galactopyranosyl)oxy]-3-hydroxyoctadec-4-en-2-yl}dodecanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;20% PEG3350, 200 mM sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.86 Å
R-free 0.291
|
|
4F7E
Crystal structure of bovine CD1d with bound C16:0-alpha-galactosyl ceramide
Deposited 2012-05-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
21–118(98 aa)
Fragment:UNP residues 21-118
|
Not recorded
|
0SH N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexadecanamide × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;20% PEG4000, 200 mM potassium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.40 Å
R-free 0.276
|
|
4IIQ
Crystal structure of a human MAIT TCR in complex with bovine MR1
Deposited 2012-12-20
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
21–118(98 aa)
Fragment:UNP C1ITJ8 residues 19-295, UNP P01888 residues 21-118
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;0.1 M Hepes, 1.5 M Ammonium Sulfate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.86 Å
R-free 0.271
|
|
4L8S
Crystal structure of a human Valpha7.2/Vbeta13.3 MAIT TCR in complex with bovine MR1
Deposited 2013-06-17
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
21–118(98 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;0.1 M Hepes, 1.7 M Ammonium Sulfate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291.0K
|
Resolution 2.90 Å
R-free 0.278
|
|
4L9L
Crystal structure of a human Valpha7.2/Vbeta13.2 MAIT TCR in complex with bovine MR1
Deposited 2013-06-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
21–118(98 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;0.1 M Hepes, 1.6 M Ammonium Sulfate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291.0K
|
Resolution 3.40 Å
R-free 0.312
|
|
4L9L
Crystal structure of a human Valpha7.2/Vbeta13.2 MAIT TCR in complex with bovine MR1
Deposited 2013-06-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
21–118(98 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;0.1 M Hepes, 1.6 M Ammonium Sulfate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291.0K
|
Resolution 3.40 Å
R-free 0.312
|
|
7RNO
Model of the Ac-6-FP/hpMR1/bB2m/TAPBPR complex from integrated docking, NMR and restrained MD
Deposited 2021-07-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
21–118(98 aa)
|
Not recorded
|
30W N-(6-formyl-4-oxo-3,4-dihydropteridin-2-yl)acetamide × 1
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;298.15 K;Ionic strength (raw mmCIF value) 50;Pressure 1.01325
NMR sample composition
100 uM hpMR1 (human platform MR1), 100 uM [U-100% 12C; U-100% 15N; Ala CB, Ile CD1, Leu CD1/CD2, Val CG1/CG2] bovine beta 2 microglobulin, 300 uM TAPBPR, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|